Key points are not available for this paper at this time.
NPC patients with low levels of CD19+ B cells or CD4+ T cells before treatment have a poor prognosis. In addition, chemoradiotherapy may reduce the body's immune function in NPC patients.
Shen et al. (Fri,) studied this question.